The document "Metabolomics for Pharmaceutical Applications - Vol 1" provides an in-depth exploration of how metabolomics is applied in drug development and translational research. It highlights the potential of metabolomics to discover and validate biomarkers that can aid in making critical decisions throughout the drug development process, from discovery to clinical trials. The book discusses several case studies where Metabolon’s proprietary small molecule database and expert team contributed to significant breakthroughs in understanding and treating complex diseases, such as drug-resistant relapsed leukemia, lung cancer, acute renal injury, mitral valve disease in dogs, and lymphangioleiomyomatosis (LAM).

Join for free to read